Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections

Background. Staphylococcus aureus has numerous virulence factors, including exotoxins that may increase the severity of infection. This study was aimed at assessing whether preexisting antibodies to S. aureus toxins are associated with a lower risk of sepsis in adults with S. aureus infection compli...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 206; no. 6; pp. 915 - 923
Main Authors Adhikari, Rajan P., Ajao, Adebola O., Aman, M. Javad, Karauzum, Hatice, Sarwar, Jawad, Lydecker, Alison D., Johnson, J. Kristie, Nguyen, Chinh, Chen, Wilbur H., Roghmann, Mary-Claire
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 15.09.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background. Staphylococcus aureus has numerous virulence factors, including exotoxins that may increase the severity of infection. This study was aimed at assessing whether preexisting antibodies to S. aureus toxins are associated with a lower risk of sepsis in adults with S. aureus infection complicated by bacteremia. Methods. We prospectively identified adults with S. aureus infection from 4 hospitals in Baltimore, MD, in 2009-2011. We obtained serum samples from prior to or at presentation of S. aureus bacteremia to measure total immunoglobulin G (IgG) and IgG antibody levels to 11 S. aureus exotoxins. Bacterial isolates were tested for the genes encoding S. aureus exotoxins using polymerase chain reaction (PCR). Results. One hundred eligible subjects were included and 27 of them developed sepsis. When adjusted for total IgG levels and stratified for the presence of toxin in the infecting isolate as appropriate, the risk of sepsis was significantly lower in those patients with higher levels of IgG against δ-hemolysin (Hla), δ-hemolysin (Hld), Panton Valentine leukocidin (PVL), staphylococcal enterotoxin C-1 (SEC-1), and phenol-soluble modulin α3 (PSM-α3). Conclusions. Our results suggest that higher antibody levels against Hla, Hid, PVL, SEC-1, and PSM-α3 may protect against sepsis in patients with invasive S. aureus infections.
AbstractList Background. Staphylococcus aureus has numerous virulence factors, including exotoxins that may increase the severity of infection. This study was aimed at assessing whether preexisting antibodies to S. aureus toxins are associated with a lower risk of sepsis in adults with S. aureus infection complicated by bacteremia. Methods. We prospectively identified adults with S. aureus infection from 4 hospitals in Baltimore, MD, in 2009-2011. We obtained serum samples from prior to or at presentation of S. aureus bacteremia to measure total immunoglobulin G (IgG) and IgG antibody levels to 11 S. aureus exotoxins. Bacterial isolates were tested for the genes encoding S. aureus exotoxins using polymerase chain reaction (PCR). Results. One hundred eligible subjects were included and 27 of them developed sepsis. When adjusted for total IgG levels and stratified for the presence of toxin in the infecting isolate as appropriate, the risk of sepsis was significantly lower in those patients with higher levels of IgG against δ-hemolysin (Hla), δ-hemolysin (Hld), Panton Valentine leukocidin (PVL), staphylococcal enterotoxin C-1 (SEC-1), and phenol-soluble modulin α3 (PSM-α3). Conclusions. Our results suggest that higher antibody levels against Hla, Hid, PVL, SEC-1, and PSM-α3 may protect against sepsis in patients with invasive S. aureus infections.
Staphylococcus aureus has numerous virulence factors, including exotoxins that may increase the severity of infection. This study was aimed at assessing whether preexisting antibodies to S. aureus toxins are associated with a lower risk of sepsis in adults with S. aureus infection complicated by bacteremia. We prospectively identified adults with S. aureus infection from 4 hospitals in Baltimore, MD, in 2009–2011. We obtained serum samples from prior to or at presentation of S. aureus bacteremia to measure total immunoglobulin G (IgG) and IgG antibody levels to 11 S. aureus exotoxins. Bacterial isolates were tested for the genes encoding S. aureus exotoxins using polymerase chain reaction (PCR). One hundred eligible subjects were included and 27 of them developed sepsis. When adjusted for total IgG levels and stratified for the presence of toxin in the infecting isolate as appropriate, the risk of sepsis was significantly lower in those patients with higher levels of IgG against α-hemolysin (Hla), δ-hemolysin (Hld), Panton Valentine leukocidin (PVL), staphylococcal enterotoxin C-1 (SEC-1), and phenol-soluble modulin α3 (PSM-α3). Our results suggest that higher antibody levels against Hla, Hld, PVL, SEC-1, and PSM-α3 may protect against sepsis in patients with invasive S. aureus infections.
Staphylococcus aureus has numerous virulence factors, including exotoxins that may increase the severity of infection. This study was aimed at assessing whether preexisting antibodies to S. aureus toxins are associated with a lower risk of sepsis in adults with S. aureus infection complicated by bacteremia.BACKGROUNDStaphylococcus aureus has numerous virulence factors, including exotoxins that may increase the severity of infection. This study was aimed at assessing whether preexisting antibodies to S. aureus toxins are associated with a lower risk of sepsis in adults with S. aureus infection complicated by bacteremia.We prospectively identified adults with S. aureus infection from 4 hospitals in Baltimore, MD, in 2009–2011. We obtained serum samples from prior to or at presentation of S. aureus bacteremia to measure total immunoglobulin G (IgG) and IgG antibody levels to 11 S. aureus exotoxins. Bacterial isolates were tested for the genes encoding S. aureus exotoxins using polymerase chain reaction (PCR).METHODSWe prospectively identified adults with S. aureus infection from 4 hospitals in Baltimore, MD, in 2009–2011. We obtained serum samples from prior to or at presentation of S. aureus bacteremia to measure total immunoglobulin G (IgG) and IgG antibody levels to 11 S. aureus exotoxins. Bacterial isolates were tested for the genes encoding S. aureus exotoxins using polymerase chain reaction (PCR).One hundred eligible subjects were included and 27 of them developed sepsis. When adjusted for total IgG levels and stratified for the presence of toxin in the infecting isolate as appropriate, the risk of sepsis was significantly lower in those patients with higher levels of IgG against α-hemolysin (Hla), δ-hemolysin (Hld), Panton Valentine leukocidin (PVL), staphylococcal enterotoxin C-1 (SEC-1), and phenol-soluble modulin α3 (PSM-α3).RESULTSOne hundred eligible subjects were included and 27 of them developed sepsis. When adjusted for total IgG levels and stratified for the presence of toxin in the infecting isolate as appropriate, the risk of sepsis was significantly lower in those patients with higher levels of IgG against α-hemolysin (Hla), δ-hemolysin (Hld), Panton Valentine leukocidin (PVL), staphylococcal enterotoxin C-1 (SEC-1), and phenol-soluble modulin α3 (PSM-α3).Our results suggest that higher antibody levels against Hla, Hld, PVL, SEC-1, and PSM-α3 may protect against sepsis in patients with invasive S. aureus infections.CONCLUSIONSOur results suggest that higher antibody levels against Hla, Hld, PVL, SEC-1, and PSM-α3 may protect against sepsis in patients with invasive S. aureus infections.
Author Aman, M. Javad
Johnson, J. Kristie
Roghmann, Mary-Claire
Nguyen, Chinh
Adhikari, Rajan P.
Chen, Wilbur H.
Ajao, Adebola O.
Karauzum, Hatice
Sarwar, Jawad
Lydecker, Alison D.
Author_xml – sequence: 1
  givenname: Rajan P.
  surname: Adhikari
  fullname: Adhikari, Rajan P.
– sequence: 2
  givenname: Adebola O.
  surname: Ajao
  fullname: Ajao, Adebola O.
– sequence: 3
  givenname: M. Javad
  surname: Aman
  fullname: Aman, M. Javad
– sequence: 4
  givenname: Hatice
  surname: Karauzum
  fullname: Karauzum, Hatice
– sequence: 5
  givenname: Jawad
  surname: Sarwar
  fullname: Sarwar, Jawad
– sequence: 6
  givenname: Alison D.
  surname: Lydecker
  fullname: Lydecker, Alison D.
– sequence: 7
  givenname: J. Kristie
  surname: Johnson
  fullname: Johnson, J. Kristie
– sequence: 8
  givenname: Chinh
  surname: Nguyen
  fullname: Nguyen, Chinh
– sequence: 9
  givenname: Wilbur H.
  surname: Chen
  fullname: Chen, Wilbur H.
– sequence: 10
  givenname: Mary-Claire
  surname: Roghmann
  fullname: Roghmann, Mary-Claire
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26350253$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22807524$$D View this record in MEDLINE/PubMed
BookMark eNp10c1u1DAUBWALFdFpYckS5A0Sm7T-iWNnGVWFjjQSiwGxjBzbUT3K2MHXGTq8A-9MqkyLhMTqLvzda-mcC3QWYnAIvaXkipKaX_vQWw_XOw9lxV6gFRVcFlVF-RlaEcJYQVVdn6MLgB0hpOSVfIXOGVNEClau0O9N_OkSbkL2XbRHvHEHNwDOEW-zHu-PQzTRmAmwnpKbx-1DzPHBB8BNcrgBiMbr7Cz-7vM93roRPGAf8F2E0Wc9-F_zW2OnIcNC1uGgwR8c3l493VyH3pnsY4DX6GWvB3BvTvMSfft0-_Xmrth8-by-aTaF4aXIhWKl5T1TnZZE1nVvrZLWGuk4UVRywYnUXcXnYUXJOse4UpQI3dFKmk4Lfok-LnfHFH9MDnK792DcMOjg4gQtJVwqxamoZ_r-RKdu72w7Jr_X6dg-RTiDDyegweihTzoYD39dxQVhgs-uWJxJESC5_plQ0j5W2S5VtkuVs-f_eDMH-hhTTtoP_916t2ztIMf0_EVJJRNVrfgfFRiwKw
CODEN JIDIAQ
CitedBy_id crossref_primary_10_1002_prca_201400123
crossref_primary_10_1128_mBio_00910_19
crossref_primary_10_1111_1469_0691_12570
crossref_primary_10_1038_srep24754
crossref_primary_10_1002_cti2_1009
crossref_primary_10_4161_19420862_2014_985132
crossref_primary_10_1517_13543784_2016_1109077
crossref_primary_10_1128_mBio_01949_18
crossref_primary_10_1093_infdis_jiu198
crossref_primary_10_3389_fimmu_2019_00114
crossref_primary_10_3390_ijms25126486
crossref_primary_10_3390_toxins8040095
crossref_primary_10_4161_viru_23905
crossref_primary_10_1038_srep29373
crossref_primary_10_1128_microbiolspec_GPP3_0036_2018
crossref_primary_10_1016_j_burns_2012_12_008
crossref_primary_10_3390_toxins14070450
crossref_primary_10_1016_j_jim_2016_01_013
crossref_primary_10_1080_21645515_2016_1248326
crossref_primary_10_1186_s13054_015_0793_0
crossref_primary_10_3390_toxins6030950
crossref_primary_10_1016_j_cmi_2017_02_035
crossref_primary_10_3389_fimmu_2021_651619
crossref_primary_10_1016_j_jprot_2015_06_018
crossref_primary_10_1172_JCI130728
crossref_primary_10_3389_fcimb_2017_00518
crossref_primary_10_1093_infdis_jit421
crossref_primary_10_1128_IAI_00671_17
crossref_primary_10_1042_BCJ20180691
crossref_primary_10_1080_14760584_2016_1179583
crossref_primary_10_1016_j_micpath_2023_106316
crossref_primary_10_1371_journal_ppat_1007395
crossref_primary_10_1007_s10096_014_2307_4
crossref_primary_10_1038_s41598_019_39890_z
crossref_primary_10_1016_j_intimp_2019_106009
crossref_primary_10_3390_toxins12060408
crossref_primary_10_1093_femsre_fuv024
crossref_primary_10_4161_hv_27692
crossref_primary_10_1016_j_xcrm_2023_101360
crossref_primary_10_1080_21645515_2018_1440105
crossref_primary_10_1016_j_bbrep_2024_101648
crossref_primary_10_3389_fcimb_2022_1060810
crossref_primary_10_1080_21505594_2017_1362532
crossref_primary_10_3390_toxins12070450
crossref_primary_10_3346_jkms_2023_38_e129
crossref_primary_10_1016_j_ijbiomac_2024_134099
crossref_primary_10_3390_ijms232416086
crossref_primary_10_3390_toxins5061140
crossref_primary_10_1128_AAC_00357_16
crossref_primary_10_1002_cti2_1070
crossref_primary_10_1007_s10482_016_0690_9
crossref_primary_10_3389_fimmu_2021_624310
crossref_primary_10_1089_omi_2019_0183
crossref_primary_10_1371_journal_pone_0137874
crossref_primary_10_1093_infdis_jiw441
crossref_primary_10_3389_fmicb_2016_00963
crossref_primary_10_1038_s41579_022_00686_0
crossref_primary_10_1111_1574_6976_12057
crossref_primary_10_1080_21505594_2017_1320012
crossref_primary_10_1128_IAI_01558_13
crossref_primary_10_1371_journal_pone_0065384
crossref_primary_10_1093_infdis_jiaa602
crossref_primary_10_3390_pathogens10020091
crossref_primary_10_1093_cid_cit123
crossref_primary_10_2217_fmb_13_153
crossref_primary_10_1128_CVI_00399_16
crossref_primary_10_1128_mBio_02125_17
crossref_primary_10_4049_jimmunol_1600093
crossref_primary_10_1002_prca_201600050
crossref_primary_10_1038_nrmicro_2017_27
crossref_primary_10_1371_journal_pone_0116847
crossref_primary_10_1128_JCM_02023_14
crossref_primary_10_2217_fmb_13_37
crossref_primary_10_1128_CVI_00091_16
crossref_primary_10_1016_j_ijmm_2013_11_008
crossref_primary_10_1080_21505594_2017_1391447
crossref_primary_10_3390_microorganisms8121936
crossref_primary_10_3390_toxins11060339
crossref_primary_10_1146_annurev_micro_041222_024605
crossref_primary_10_1016_j_jmb_2013_02_008
crossref_primary_10_1080_19420862_2022_2083467
crossref_primary_10_1080_21645515_2015_1011021
crossref_primary_10_4161_hv_25182
crossref_primary_10_1160_th15_04_0322
crossref_primary_10_3390_toxins10060252
crossref_primary_10_1371_journal_ppat_1005226
crossref_primary_10_1093_infdis_jit501
crossref_primary_10_1097_PCC_0000000000001053
crossref_primary_10_1186_s12941_016_0125_5
crossref_primary_10_1016_j_lfs_2020_118685
crossref_primary_10_1038_s41435_020_0101_0
crossref_primary_10_1099_mic_0_000759
crossref_primary_10_1128_IAI_00667_15
crossref_primary_10_1093_femsre_fuz030
crossref_primary_10_3390_toxins13100677
crossref_primary_10_3390_microorganisms6010025
crossref_primary_10_1016_j_vaccine_2016_09_061
crossref_primary_10_1128_mBio_02369_14
crossref_primary_10_1590_1519_6984_242703
crossref_primary_10_3389_fimmu_2022_893921
crossref_primary_10_1159_000499184
crossref_primary_10_1084_jem_20190541
crossref_primary_10_1172_jci_insight_173526
crossref_primary_10_3389_fvets_2021_639141
crossref_primary_10_1016_j_injury_2024_111631
crossref_primary_10_1093_infdis_jiaa482
crossref_primary_10_3390_toxins13100726
crossref_primary_10_1164_rccm_201406_1012OC
crossref_primary_10_1080_19420862_2016_1215791
crossref_primary_10_1128_msystems_00632_19
crossref_primary_10_1016_j_chembiol_2022_04_003
Cites_doi 10.1128/JCM.02094-09
10.1128/JCM.27.6.1286-1291.1989
10.1086/503048
10.1056/NEJMoa055356
10.1016/j.chom.2010.05.012
10.1128/IAI.30.1.36-42.1980
10.1128/IAI.27.2.431-434.1980
10.1073/pnas.0912403107
10.1016/S0140-6736(04)16897-9
10.1016/S0065-2776(08)60534-9
10.1016/0022-5193(82)90299-5
10.1038/nm1656
10.1086/656043
10.1096/fj.10-175208
10.4049/jimmunol.120.1.86
10.1099/00222615-44-3-171
10.1128/JB.182.22.6517-6522.2000
10.1128/IAI.00679-07
10.1086/596743
10.1371/journal.pone.0006387
10.1016/j.idc.2008.10.005
10.1128/IAI.72.7.4061-4071.2004
10.1046/j.1365-2958.2003.03526.x
10.1001/archinte.163.17.2066
10.1016/j.idc.2008.10.003
10.1086/648673
10.1371/journal.pone.0007204
10.1086/648613
10.1128/IAI.8.6.938-946.1973
10.1016/j.vaccine.2011.04.033
10.1128/CMR.13.1.16-34.2000
10.1111/j.1469-0691.2009.03073.x
10.1128/IAI.67.10.5541-5544.1999
10.1110/ps.4360102
10.4161/viru.2.6.17732
10.1128/IAI.45.1.281-285.1984
10.1128/IAI.64.5.1839-1841.1996
10.1016/S0140-6736(02)07877-7
10.1086/512627
10.1086/592053
10.1086/605332
ContentType Journal Article
Copyright Copyright © 2012 Oxford University Press on behalf of the Infectious Diseases Society of America
2015 INIST-CNRS
Copyright_xml – notice: Copyright © 2012 Oxford University Press on behalf of the Infectious Diseases Society of America
– notice: 2015 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/infdis/jis462
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 923
ExternalDocumentID 22807524
26350253
10_1093_infdis_jis462
41725698
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-~X
..I
.2P
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACGFO
ACGFS
ACGOD
ACHIC
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
EBS
ECGQY
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
IPSME
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TR2
W2D
W8F
WH7
X7H
YAYTL
YKOAZ
YXANX
~91
AAYXX
CITATION
.55
.GJ
3O-
41~
AAFWJ
AAPGJ
AAWDT
ABDPE
ABSMQ
ACFRR
ACPQN
ACVCV
ACZBC
ADMTO
AEKPW
AFFQV
AFHKK
AFQQW
AFSHK
AGKRT
AGMDO
AHGBF
AI.
AJDVS
APJGH
AQDSO
AQKUS
AVNTJ
BZKNY
EIHJH
HQ3
HTVGU
IQODW
J5H
MBLQV
MVM
N4W
NEJ
OBFPC
O~Y
P0-
TMA
VH1
X7M
Y6R
ZE2
ZGI
ZXP
ADJQC
ADRIX
AFXEN
CGR
CUY
CVF
DOOOF
ECM
EIF
ESX
JSODD
M49
NPM
VXZ
YIF
7X8
ID FETCH-LOGICAL-c345t-824d3f28ba70799fdd87ddc7e3081735307ab63307d542be2388105ab167cba53
ISSN 0022-1899
1537-6613
IngestDate Fri Jul 11 10:54:30 EDT 2025
Wed Feb 19 01:52:44 EST 2025
Mon Jul 21 09:14:31 EDT 2025
Tue Jul 01 02:51:49 EDT 2025
Thu Apr 24 22:57:52 EDT 2025
Fri Jun 20 02:31:52 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Infection
Sepsis syndrome
Toxin
Antibody
Bacteria
Micrococcales
Micrococcaceae
Exotoxin
Staphylococcus aureus
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c345t-824d3f28ba70799fdd87ddc7e3081735307ab63307d542be2388105ab167cba53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22807524
PQID 1037883159
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1037883159
pubmed_primary_22807524
pascalfrancis_primary_26350253
crossref_primary_10_1093_infdis_jis462
crossref_citationtrail_10_1093_infdis_jis462
jstor_primary_41725698
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-09-15
PublicationDateYYYYMMDD 2012-09-15
PublicationDate_xml – month: 09
  year: 2012
  text: 2012-09-15
  day: 15
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2012
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Tseng (31_35341516) 2009; 4
Gillet (34_16953564) 2002; 359
(33_36714542) 2010; 48
(9_28942589) 2007; 75
Wertheim (4_18298918) 2004; 364
Novick (22_17664005) 2003; 48
Wang (24_30041527) 2007; 13
(26_38592258) 2009; 200
Deleo (5_33491894) 2009; 23
Kretschmer (25_37456815) 2010; 7
Jarraud (21_10529019) 2000; 182
Wergeland (7_5330723) 1989; 27
Rasigade (32_39822629) 2011; 29
Kotzin (39_14454973) 1993; 54
Moran (1_22466085) 2006; 355
Brown (16_8251421) 1980; 30
(19_38502660) 2008; 198
Freer (20_8655609) 1982; 94
Schaffer (6_33491910) 2009; 23
Holtfreter (37_18234713) 2004; 72
(11_38533002) 2010; 50
Lee (42_8122352) 1980; 27
(27_38878878) 2011; 25
(29_36717315) 2010
Miles (35_16972029) 2002; 11
Holtfreter (38_18729710) 2005; 53
Bhakdi (14_9715436) 1991; 55
McElroy (15_10974070) 1999; 67
Thompson (43_13246770) 1984; 45
Dinges (40_6428896) 2000; 13
Malachowa (36_40943197) 2011; 2
Menzies (17_16208713) 1996; 64
Spero (41_4514046) 1978; 120
(30_38589852) 2010; 201
(8_38436197) 2006; 193
Kanclerski (10_16215047) 1996; 44
Verkaik (12_35803732) 2010; 16
Fowler (2_17822943) 2003; 163
Cremieux (28_35663067) 2009; 4
(13_38591388) 2009; 199
(18_38405537) 2010; 202
Thelestam (23_12647689) 1973; 8
Shurland (3_23704858) 2007; 28
References_xml – volume: 48
  start-page: 1527
  issn: 0095-1137
  issue: 5
  year: 2010
  ident: 33_36714542
  publication-title: Journal of Clinical Microbiology
  doi: 10.1128/JCM.02094-09
– volume: 27
  start-page: 1286
  issn: 0095-1137
  issue: 6
  year: 1989
  ident: 7_5330723
  publication-title: Journal of Clinical Microbiology
  doi: 10.1128/JCM.27.6.1286-1291.1989
– volume: 193
  start-page: 1275
  issn: 0022-1899
  issue: 9
  year: 2006
  ident: 8_38436197
  publication-title: Journal of Infectious Diseases
  doi: 10.1086/503048
– volume: 355
  start-page: 666
  issn: 0028-4793
  issue: 7
  year: 2006
  ident: 1_22466085
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMoa055356
– volume: 7
  start-page: 463
  issn: 1934-6069
  issue: 6
  year: 2010
  ident: 25_37456815
  doi: 10.1016/j.chom.2010.05.012
– volume: 30
  start-page: 36
  issn: 0019-9567
  issue: 1
  year: 1980
  ident: 16_8251421
  publication-title: Infection and Immunity
  doi: 10.1128/IAI.30.1.36-42.1980
– volume: 53
  start-page: 13
  issn: 0004-069X
  issue: 1
  year: 2005
  ident: 38_18729710
  publication-title: Archivum immunologiae et therapiae experimentalis
– volume: 27
  start-page: 431
  issn: 0019-9567
  issue: 2
  year: 1980
  ident: 42_8122352
  publication-title: Infection and Immunity
  doi: 10.1128/IAI.27.2.431-434.1980
– issn: 0027-8424
  year: 2010
  ident: 29_36717315
  publication-title: PNAS
  doi: 10.1073/pnas.0912403107
– volume: 364
  start-page: 703
  issn: 0140-6736
  issue: 9435
  year: 2004
  ident: 4_18298918
  publication-title: Lancet
  doi: 10.1016/S0140-6736(04)16897-9
– volume: 54
  start-page: 99
  issn: 0065-2776
  year: 1993
  ident: 39_14454973
  publication-title: Advances in immunology
  doi: 10.1016/S0065-2776(08)60534-9
– volume: 94
  start-page: 535
  issn: 1095-8541
  issue: 3
  year: 1982
  ident: 20_8655609
  publication-title: Journal of Theoretical Biology
  doi: 10.1016/0022-5193(82)90299-5
– volume: 13
  start-page: 1510
  issn: 1078-8956
  issue: 12
  year: 2007
  ident: 24_30041527
  publication-title: Nature medicine
  doi: 10.1038/nm1656
– volume: 202
  start-page: 1050
  issn: 0022-1899
  issue: 7
  year: 2010
  ident: 18_38405537
  publication-title: Journal of Infectious Diseases
  doi: 10.1086/656043
– volume: 25
  start-page: 1254
  issn: 0892-6638
  issue: 4
  year: 2011
  ident: 27_38878878
  publication-title: The FASEB Journal
  doi: 10.1096/fj.10-175208
– volume: 120
  start-page: 86
  issn: 0022-1767
  issue: 1
  year: 1978
  ident: 41_4514046
  publication-title: The Journal of Immunology
  doi: 10.4049/jimmunol.120.1.86
– volume: 44
  start-page: 171
  issn: 0022-2615
  issue: 3
  year: 1996
  ident: 10_16215047
  publication-title: Journal of Medical Microbiology
  doi: 10.1099/00222615-44-3-171
– volume: 182
  start-page: 6517
  issn: 0021-9193
  issue: 22
  year: 2000
  ident: 21_10529019
  publication-title: Journal of Bacteriology
  doi: 10.1128/JB.182.22.6517-6522.2000
– volume: 75
  start-page: 4534
  issn: 0019-9567
  issue: 9
  year: 2007
  ident: 9_28942589
  publication-title: Infection and Immunity
  doi: 10.1128/IAI.00679-07
– volume: 199
  start-page: 625
  issn: 0022-1899
  issue: 5
  year: 2009
  ident: 13_38591388
  publication-title: Journal of Infectious Diseases
  doi: 10.1086/596743
– volume: 4
  start-page: e6387
  issn: 1932-6203
  issue: 7
  year: 2009
  ident: 31_35341516
  doi: 10.1371/journal.pone.0006387
– volume: 23
  start-page: 153
  issn: 0891-5520
  issue: 1
  year: 2009
  ident: 6_33491910
  publication-title: Infectious disease clinics of North America
  doi: 10.1016/j.idc.2008.10.005
– volume: 72
  start-page: 4061
  issn: 0019-9567
  issue: 7
  year: 2004
  ident: 37_18234713
  publication-title: Infection and Immunity
  doi: 10.1128/IAI.72.7.4061-4071.2004
– volume: 48
  start-page: 1429
  issn: 0950-382X
  issue: 6
  year: 2003
  ident: 22_17664005
  publication-title: Molecular microbiology
  doi: 10.1046/j.1365-2958.2003.03526.x
– volume: 163
  start-page: 2066
  issn: 0003-9926
  issue: 17
  year: 2003
  ident: 2_17822943
  publication-title: Archives of Internal Medicine
  doi: 10.1001/archinte.163.17.2066
– volume: 23
  start-page: 17
  issn: 0891-5520
  issue: 1
  year: 2009
  ident: 5_33491894
  publication-title: Infectious disease clinics of North America
  doi: 10.1016/j.idc.2008.10.003
– volume: 50
  start-page: 61
  issn: 1058-4838
  issue: 1
  year: 2010
  ident: 11_38533002
  publication-title: Clinical Infectious Diseases
  doi: 10.1086/648673
– volume: 4
  start-page: e7204
  issn: 1932-6203
  issue: 9
  year: 2009
  ident: 28_35663067
  doi: 10.1371/journal.pone.0007204
– volume: 201
  start-page: 92
  issn: 0022-1899
  issue: 1
  year: 2010
  ident: 30_38589852
  publication-title: Journal of Infectious Diseases
  doi: 10.1086/648613
– volume: 8
  start-page: 938
  issn: 0019-9567
  issue: 6
  year: 1973
  ident: 23_12647689
  publication-title: Infection and Immunity
  doi: 10.1128/IAI.8.6.938-946.1973
– volume: 29
  start-page: 4185
  issn: 1873-2518
  issue: 25
  year: 2011
  ident: 32_39822629
  doi: 10.1016/j.vaccine.2011.04.033
– volume: 13
  start-page: 16
  issn: 0893-8512
  issue: 1
  year: 2000
  ident: 40_6428896
  publication-title: Clinical Microbiology Reviews
  doi: 10.1128/CMR.13.1.16-34.2000
– volume: 16
  start-page: 1312
  issn: 1198-743X
  issue: 8
  year: 2010
  ident: 12_35803732
  publication-title: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  doi: 10.1111/j.1469-0691.2009.03073.x
– volume: 67
  start-page: 5541
  issn: 0019-9567
  issue: 10
  year: 1999
  ident: 15_10974070
  publication-title: Infection and Immunity
  doi: 10.1128/IAI.67.10.5541-5544.1999
– volume: 11
  start-page: 894
  issn: 0961-8368
  issue: 4
  year: 2002
  ident: 35_16972029
  publication-title: Protein Science
  doi: 10.1110/ps.4360102
– volume: 2
  start-page: 567
  issn: 2150-5608
  issue: 6
  year: 2011
  ident: 36_40943197
  doi: 10.4161/viru.2.6.17732
– volume: 45
  start-page: 281
  issn: 0019-9567
  issue: 1
  year: 1984
  ident: 43_13246770
  publication-title: Infection and Immunity
  doi: 10.1128/IAI.45.1.281-285.1984
– volume: 64
  start-page: 1839
  issn: 0019-9567
  issue: 5
  year: 1996
  ident: 17_16208713
  publication-title: Infection and Immunity
  doi: 10.1128/IAI.64.5.1839-1841.1996
– volume: 55
  start-page: 733
  issn: 1092-2172
  issue: 4
  year: 1991
  ident: 14_9715436
  publication-title: Microbiology and Molecular Biology Reviews
– volume: 359
  start-page: 753
  issn: 0140-6736
  issue: 9308
  year: 2002
  ident: 34_16953564
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)07877-7
– volume: 28
  start-page: 273
  issn: 0899-823X
  issue: 3
  year: 2007
  ident: 3_23704858
  publication-title: Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America
  doi: 10.1086/512627
– volume: 198
  start-page: 1166
  issn: 0022-1899
  issue: 8
  year: 2008
  ident: 19_38502660
  publication-title: Journal of Infectious Diseases
  doi: 10.1086/592053
– volume: 200
  start-page: 715
  issn: 0022-1899
  issue: 5
  year: 2009
  ident: 26_38592258
  publication-title: Journal of Infectious Diseases
  doi: 10.1086/605332
SSID ssj0004367
Score 2.4391613
Snippet Background. Staphylococcus aureus has numerous virulence factors, including exotoxins that may increase the severity of infection. This study was aimed at...
Staphylococcus aureus has numerous virulence factors, including exotoxins that may increase the severity of infection. This study was aimed at assessing...
SourceID proquest
pubmed
pascalfrancis
crossref
jstor
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 915
SubjectTerms Adult
Aged
Antibodies
Antibodies, Bacterial - blood
Bacteremia
BACTERIA
Bacterial Proteins - immunology
Bacteriology
Biological and medical sciences
Cohort Studies
Enterotoxins
Exotoxins
Exotoxins - immunology
Female
Fundamental and applied biological sciences. Psychology
Hospitalization
Humans
Immunoglobulin G - blood
Infections
Infectious diseases
Leukocidins
Male
Medical sciences
Microbiology
Middle Aged
Miscellaneous
Odds Ratio
Risk Factors
Sepsis
Sepsis - immunology
Sepsis - microbiology
Staphylococcal Infections - immunology
Staphylococcal Infections - microbiology
Staphylococcus
Staphylococcus aureus
Staphylococcus aureus - immunology
Staphylococcus aureus - metabolism
Toxins
Title Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections
URI https://www.jstor.org/stable/41725698
https://www.ncbi.nlm.nih.gov/pubmed/22807524
https://www.proquest.com/docview/1037883159
Volume 206
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIiXCQYbHTAZCfFS0rVxro8R29R26ybRFSZeIjtxpFZTMrUp2vYf-GH8K459ciswbi9JlZzaVb8vx-c4x58JeZOYHFI0YRvSjiIDSNE3PFv2DW65jNmsxx09mTM-dQZTa3RhX7Ra3xpVS6tcdKPbX64r-R9U4RrgqlbJ_gOyVaNwAT4DvnAEhOH4VxifZLrEPc1nIotvOieqAEgrNkAICX8fjFNZFK2WHb5aSDgdXmd5dq1qYoKFrICBiPOTmoydyCslTqK0r4q9RGa3cC9QAh1LNBmmX7gud590yzaHRTFXMek3r8k3ampSoBHYFy-Eqkg-OBgMj4MPQw01nyuXXN0aBWfadcXgEy9556yq9gk-BgcdGC1O16ZzoZlg-nk61qMpL4v6yikNVRviG7io83dLJZtuHDLovoc7K5Vu3Ow5Db42nbJftI3ju4_rm38aOlBWCy7FStzhaD5bWsU4sSbS_cPgWZU0KlEfiB_ZPXLfhIxFZ_fD43qJLnPcUrhe_fJC7hU63ccu97HDtfAIK2RVuS5fwhOb4FYrd-dCOiY6f0w2C4RpgMx8Qloy3SIPcHvTmy3ycFwUbjwlXzVVaUlVilSleUbXqUqRVrSiKjQuaU1VqnhIkap0ltImVSlSFU1KqtJJt2yzpuozMj06PH8_MIqdQIyIWXZueKYVs8T0BFeCjn4Sx54bx5ErGUS0rvIpLhcOg1NsW6aQEId6kDhw0XfcSHCbbZONNEvlc0ITUygBCEcoFatIxn4iE5b0PNfzEzO2-23yrgQgjAqZfLVby2WI5RosRLxCxKtN3lbmV6gPc5fhtkazsrIgdbAd32uTvTV4K4OSUW3yusQ7BN-vXujxVMIjG6o1vp7HICNpkx0kQv1tJXNlm9bun5p_QR7Vz-BLspEvVvIVBNq52NMU_g5cmdrV
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lower+Antibody+Levels+to+Staphylococcus+aureus+Exotoxins+Are+Associated+With+Sepsis+in+Hospitalized+Adults+With+Invasive+S.+aureus+Infections&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=ADHIKARI%2C+Rajan+P&rft.au=AJAO%2C+Adebola+O&rft.au=JAVAD+AMAN%2C+M&rft.au=KARAUZUM%2C+Hatice&rft.date=2012-09-15&rft.pub=Oxford+University+Press&rft.issn=0022-1899&rft.volume=206&rft.issue=6&rft.spage=915&rft.epage=923&rft_id=info:doi/10.1093%2Finfdis%2Fjis462&rft.externalDBID=n%2Fa&rft.externalDocID=26350253
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon